Literature DB >> 2535740

The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26.

M F Nunn1, T Hunter.   

Abstract

E26 is a replication-defective avian retrovirus that causes an erythroblastic leukemia in vivo and transforms hematopoietic precursor cells of both the erythroid and the myeloid lineages in vitro. The E26 genome contains two sets of cell-derived sequences, ets and myb. myb sequences are also present in avian myeloblastosis virus, which transforms myeloblasts exclusively. To determine whether the ets sequence is responsible for the erythroid specificity of E26, we analyzed the transforming activities of several viruses carrying mutations in the ets sequence constructed in vitro. The mutant viruses retained the ability to transform myeloid cells in vitro, indicating that the myb oncogene is sufficient for this viral function. However, the ets-deficient viruses did not cause an overt leukemia in chickens. The results indicate that the ets sequence is required for the induction of erythroblastosis by E26.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535740      PMCID: PMC247696     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Focus assay and defectiveness of avian myeloblastosis virus.

Authors:  C Moscovici; L Gazzolo; M G Moscovici
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

2.  Multiple domains for the chicken cellular sequences homologous to the v-ets oncogene of the E26 retrovirus.

Authors:  A Gegonne; D Leprince; M Duterque-Coquillaud; B Vandenbunder; A Flourens; J Ghysdael; B Debuire; D Stehelin
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.

Authors:  B M Sefton; K Beemon; T Hunter
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

4.  Effects of genetic cellular resistance on cell transformation and virus replication in chicken hematopoietic cell cultures infected with avian myeloblastosis virus (BAI-A).

Authors:  C Moscovici; P K Vogt
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Induction of anemia by avian leukosis viruses of five subgroups.

Authors:  R E Smith; E V Schmidt
Journal:  Virology       Date:  1982-03       Impact factor: 3.616

7.  Complementary DNA clones of chicken proto-oncogene c-ets: sequence divergence from the viral oncogene v-ets.

Authors:  J H Chen
Journal:  Oncogene Res       Date:  1988-05

8.  Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene.

Authors:  K Radke; H Beug; S Kornfeld; T Graf
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

9.  Acute leukemia viruses E26 and avian myeloblastosis virus have related transformation-specific RNA sequences but different genetic structures, gene products, and oncogenic properties.

Authors:  K Bister; M Nunn; C Moscovici; B Perbal; M Baluda; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Identification in chickens of an evolutionarily conserved cellular ets-2 gene (c-ets-2) encoding nuclear proteins related to the products of the c-ets proto-oncogene.

Authors:  K E Boulukos; P Pognonec; A Begue; F Galibert; J C Gesquière; D Stéhelin; J Ghysdael
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  18 in total

1.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  A positive regulator of the ribosomal protein gene, beta factor, belongs to the ETS oncoprotein family.

Authors:  T Yoganathan; N K Bhat; B H Sells
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

3.  Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.

Authors:  C Garrido; D Leprince; J S Lipsick; D Stehelin; D Gospodarowicz; S Saule
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 4.  The ETS family of oncogenic transcription factors in solid tumours.

Authors:  Gina M Sizemore; Jason R Pitarresi; Subhasree Balakrishnan; Michael C Ostrowski
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

5.  Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.

Authors:  L W Donaldson; J M Petersen; B J Graves; L P McIntosh
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

6.  Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1.

Authors:  J J Skalicky; L W Donaldson; J M Petersen; B J Graves; L P McIntosh
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

7.  Growth factor gene activation and clonal heterogeneity in an autostimulatory myeloid leukemia.

Authors:  K B Leslie; J W Schrader
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

8.  Avian erythroblastosis virus E26: only one (myb) of two cell-derived coding regions is necessary for oncogenicity.

Authors:  Y Wu; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.

Authors:  R A Bailly; R Bosselut; J Zucman; F Cormier; O Delattre; M Roussel; G Thomas; J Ghysdael
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.